Open Letter to Vice President Mike Pence RE: US COVID-19 Response | by Dr. Maxine Dexter and Dr. Smitha Chadaga | Medical Professionals for a better COVID-19 Response | Medium
Provider Spotlight: Dr. Joel Edelstein - AZ Care Network
Coordinated Care Transforms Lives - AZ Care Network
SUNY series in American Philosophy and Cultural Thought
Cytokine release syndrome in severe COVID-19 | Science
Genentech: Brian Yaspan | Senior Principal Scientist, OMNI Human Genetics
Genetic mechanisms of critical illness in COVID-19 | Nature
Distinct inflammatory profiles distinguish COVID-19 from influenza with limited contributions from cytokine storm | Science Advances
Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies | Nature
Brown Annual Fund 2019-2020 Donor Book by Brown Annual Fund - Issuu
Discovery of 1,2,4-Triazine Derivatives as Adenosine A2A Antagonists using Structure Based Drug Design | Journal of Medicinal Chemistry
highlight - Rutgers
Pin on admirable artists.
Genomic reconstruction of the SARS-CoV-2 epidemic in England | Nature
AZ Care Network - A Better State of Care
Professor Jason Pole - Centre for Health Services Research - University of Queensland
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK - The Lancet
Axion dark matter: What is it and why now? | Science Advances
Summer Search - Annual Report
Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK - The Lancet Respiratory Medicine
Discovery of Pyridone-Substituted Triazolopyrimidine Dual A2A/A1 AR Antagonists for the Treatment of Ischemic Stroke | ACS Medicinal Chemistry Letters
Genentech: Christian Hammer | Senior Principal Scientist, Cancer Immunology & Human Genetics
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial - The Lancet
Atomistic Simulations and In Silico Mutational Profiling of Protein Stability and Binding in the SARS-CoV-2 Spike Protein Complexes with Nanobodies: Molecular Determinants of Mutational Escape Mechanisms | ACS Omega
Executive Leadership - AZ Care Network
NC State University 2020 Commencement Program by NC State Enrollment Management and Services - Issuu
